Literature DB >> 4758574

Non-specific factors that may influence significance of urinary steroid excretion in breast cancer.

J A Durant, H Miller.   

Abstract

The urinary excretion of corticosteroids (17-oxogenic steroids) and adrenal androgens (11-deoxy-17-oxosteroids) was studied in women below the age of 50 in a variety of clinical situations for comparison with a normal group. The conditions studied were: chronic debility from non-malignant disease, weight reduction, admission to hospital and surgery for varicose veins, hepatic non-malignant disease, and non-mammary cancer.The objective of the study was to determine whether the changes found in early and advanced breast cancer and used to judge the prognosis of the disease are specific to the disease or are merely incidental to the degree of illness caused by the disease.Similar changes to those found in breast cancer-principally a reduction in the excretion of the androgens-were found in the women with severe hepatic disease and in advanced non-mammary cancer. These were also found to follow the effects of severe surgical stress.It is concluded that the changes found in breast cancer are a measure of the general systemic disturbance caused by the disease and are not due specifically to it. Nevertheless, the value of their prognostic significance remains unchallenged.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4758574      PMCID: PMC1588012          DOI: 10.1136/bmj.4.5895.767

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  Abnormal excretion of urinary steroids by women with early breast cancer.

Authors:  R D BULBROOK; J L HAYWARD; C C SPICER; B S THOMAS
Journal:  Lancet       Date:  1962-12-15       Impact factor: 79.321

2.  Selection of breast-cancer patients for adrenalectomy or hypophysectomy by determination of urinary 17-hydroxycorticosteroids and aetiocholanolone.

Authors:  R D BULBROOK; F C GREENWOOD; J L HAYWARD
Journal:  Lancet       Date:  1960-05-28       Impact factor: 79.321

3.  Abnormal urinary steroid excretion and subsequent breast cancer. A prospective study in the Island of Guernsey.

Authors:  R D Bulbrook; J L Hayward
Journal:  Lancet       Date:  1967-03-11       Impact factor: 79.321

4.  Discriminant function based on steroid abnormalities in patients with lung cancer.

Authors:  L G Rao
Journal:  Lancet       Date:  1970-08-29       Impact factor: 79.321

5.  Discriminants and breast cancer.

Authors:  H Miller; J A Durant
Journal:  Lancet       Date:  1969-06-28       Impact factor: 79.321

6.  Alternative discriminating function for determining hormone dependency of breast cancer.

Authors:  H Miller; J A Durant; A G Jacobs; J F Allison
Journal:  Br Med J       Date:  1967-01-21
  6 in total
  3 in total

1.  Editorial: Breast cancer and the discriminant.

Authors: 
Journal:  Br Med J       Date:  1975-04-19

2.  Early management of the severe head injury.

Authors:  D S Gordon; H A Crockard
Journal:  Proc R Soc Med       Date:  1974-01

3.  Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer.

Authors:  A L Harris; M Dowsett; I E Smith; S Jeffcoate
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.